Usage of marginal organs for liver transplantation: A way around the critical organ shortage?;Die transplantation marginaler lebern: Ein ausweg aus dem organmangeldilemma?

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 134, Issue 2, 2009, Pages 107-112

  Pratschke, S ^a   Loehe, F ^a   Graeb, C ^a   Jauch, K W ^a   Angele, Martin K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Abdominal surgery; Clinical study; Liver surgery; Organ transplantation; Transplantation surgery

Indexed keywords

AGE; AGED; COLD ISCHEMIA; DISEASE FREE SURVIVAL; DONOR; ETHICS; FATTY LIVER; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HYPERNATREMIA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; REVIEW; TISSUE SURVIVAL; TRANSPLANTATION;

AGE FACTORS; AGED; COLD ISCHEMIA; DISEASE-FREE SURVIVAL; FATTY LIVER; GRAFT SURVIVAL; HEPATITIS C, CHRONIC; HUMANS; HYPERNATREMIA; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TISSUE SURVIVAL;

EID: 67649221280     PISSN: 0044409X     EISSN: 14389592     Source Type: Journal    
DOI: 10.1055/s-0028-1098880     Document Type: Review

References (43)

1. Adam R, Cailliez V, Majno P et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 2000; 356: 621-627
2. Adam R, Reynes M, Johann M et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 1991; 23: 1538-1540
3. Afonso RC, Hidalgo R, Paes AT et al. Impact of cumulative risk factors for expanded criteria donors on early survival after liver transplantation. Transplant Proc 2008; 40: 800-801
4. Amin MG, Wolf MP, TenBrook Jr JA et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 2004; 10: 1468-1475
5. Angele MK, Rentsch M, Hartl WH et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 2008; 195: 214-220
6. Bacchella T, Ferreira Galvao FH, Jesus de Almeida JL et al. Marginal grafts increase early mortality in liver transplantation. Sao Paulo Med J 2008; 126: 161-165
7. Barshes NR, Horwitz IB, Franzini L et al. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant 2007; 7: 1265-1270
8. Busuttil RW, Farmer DG, Yersiz H et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 2005; 241: 905-916
9. Cameron AM, Ghobrial RM, Yersiz H et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg 2006; 243: 748-753
10. Cescon M, Grazi GL, Cucchetti A et al. Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl 2008; 14: 672-679
11. Cywinski JB, Mascha E, Miller C et al. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function. Liver Transpl 2008; 14: 59-65
12. Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790
13. Ikegami T, Taketomi A, Ohta R et al. Donor age in living donor liver transplantation. Transplant Proc 2008; 40: 1471-1475
14. Imber CJ, St. Peter SD, Lopez I et al. Current practice regarding the use of fatty livers: a trans-Atlantic survey. Liver Transpl 2002; 8: 545-549
15. Koneru B, Dikdan G. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 2002; 73: 325-330
16. Kotsch K, Ulrich F, Reutzel-Selke A et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 2008; 248: 1042-1050
17. Maluf DG, Edwards EB, Kauffman HM. Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of themodel for end-stage liver disease score of the recipient? Transplantation 2006; 82: 1653-1657
18. Marsman WA, Wiesner RH, Rodriguez L et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62: 1246-1251
19. McCormack L, Petrowsky H, Jochum W et al. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007; 246: 940-946
20. Mutimer DJ, Gunson B, Chen J et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 2006; 81: 7-14
21. Neumann UP, Kaisers U, Langrehr JM et al. Administration of prostacyclin after liver transplantation: a placebo controlled randomized trial. Clin Transplant 2000; 14: 70-74
22. Nickkholgh A, Weitz J, Encke J et al. Utilization of extended donor criteria in liver transplantation: a comprehensive review of the literature. Nephrol Dial Transplant 2007; 22 Suppl 8: viii29-viii36
23. Ploeg RJ, D'Alessandro AM, Hoffmann RM et al. Impact of donor factors and preservation on function and survival after liver transplantation. Transplant Proc 1993; 25: 3031-3033
24. Pokorny H, Langer F, Herkner H et al. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant 2005; 19: 532-536
25. Ravaioli M, Grazi GL, Cescon M et al. Liver transplantations with donors aged 60 years and above: the low liver damage strategy. Transpl Int 2009; 22: 423-433
26. Reese PP, Sonawane SB, Thomasson A et al. Donor age and cold ischemia interact to produce inferior 90-day liver allograft survival. Transplantation 2008; 85: 1737-1744
27. Rentsch M, Kienle K, Mueller T et al. Adenoviral bcl-2 transfer improves survival and early graft function after ischemia and reperfusion in rat liver transplantation. Transplantation 2005; 80: 1461-1467
28. Rinella ME, Alonso E, Rao S et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001; 7: 409-414
29. Sasaki K, Miyake H, Kinoshita T et al. Protective effect of FK506 and thromboxane synthase inhibitor on ischemia-reperfusion injury in non-heart-beating donor in rat orthotopic liver transplantation. J Med Invest 2004; 51: 76-83
30. Schaubel DE, Sima CS, Goodrich NP et al. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419-425
31. Schauer RJ, Kalmuk S, Gerbes AL et al. Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation. World J Gastroenterol 2004; 10: 864-870
32. Schemmer P, Nickkholgh A, Hinz U et al. Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis. Transplant Proc 2007; 39: 529-534
33. Silberhumer GR, Pokorny H, Hetz H et al. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Transplantation 2007; 83: 588-592
34. St. Peter SD, Post DJ, Rodriguez-Davalos MI et al. Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation. Liver Transpl 2003; 9: 144-149
35. Tector AJ, Mangus RS, Chestovich P et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006; 244: 439-450
36. Todo S, Demetris AJ, Makowka L et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47: 903-905
37. Totsuka E, Dodson F, Urakami A et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg 1999; 5: 421-428
38. Zarnboni F, Franchello A, David E et al. Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 2001; 15: 53-57
39. Verran D, Kusyk T, Painter D et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003; 9: 500-505
40. Yoo HY, Molmenti E, Thuluvath PJ. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver Iransplantation. Liver Transpl 2003; 9: 72-78
41. Salizzoni M, Franchello A, Zarnboni F et al. Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 2003; 16: 486-493
42. Fernandez-Merino FJ, Nuno-Garza S, Lopez-Hervas et al. Impact of donor, recipient, and graft features an the development of primary dysfunction in liver transplants. Transplant Proc 2003; 35: 1793-1794
43. Afonso RC, Saad WA, Parra OM et al. Impact of steatotic grafts on initial function and prognosis after liver transplantation. Transplant Proc 2004; 36: 909-911